AUPHAurinia Pharmaceuticals Inc.BATS:AUPHErictaylorAUPH – Watching Pullback Within Uptrend for Continuation Keeping an eye on Aurinia Pharmaceuticals here after a strong move off the lows. The stock has been forming a higher-low structure since bottoming near the $4–5 area and recently pushed into the $15–16 zone, where it ran into resistance near the 0.618 Fibonacci retracement (~$15.54) of the larger move. Price is currently pulling back in what looks like a small falling wedge / flag consolidation, which could simply be digestion after the recent rally. The key area I’m watching is the $13 region (0.702 retracement), which lines up as a potential support zone during this pullback. Key levels on the chart: Support •~$13.00 – Fib confluence and recent breakout zone •~$10.50 – deeper support from the 0.786 retracement Resistance •~$15.50 – 0.618 retracement and recent rejection area •~$19.00 – 0.5 retracement from the larger downtrend The idea here is similar to many early-stage reversal setups: impulse move → consolidation → potential continuation higher if support holds and momentum returns. If price stabilizes above the $13 area and breaks back above $15.50, the next upside levels to watch would be $19 and $22+ based on the higher Fibonacci retracements. This is strictly a technical swing trade idea based on structure, not a long-term fundamental play. The company itself is a biotech developing therapies for autoimmune diseases, including its FDA-approved drug Lupkynis for lupus nephritis.